Category: Anal Cancer

Needs and Opportunities for Anal Cancer Prevention for PrEP Patients: A Conceptual Model

Introduction: Populations at risk for HIV infection—including gay, bisexual, and other men who have sex with men (GBM) and transgender/gender diverse people (TGD)—are at disproportionate risk for anal cancer. Most anal cancers are caused by human papillomavirus (HPV) and are preventable with HPV vaccination and screening. Engaging at-risk populations who are already receiving HIV preventive […]

UTILIZATION OF ANAL CYTOLOGY SCREENING AMONG AT-RISK SEXUAL AND GENDER MINORITY POPULATIONS IN PENNSYLVANIA

The following poster/abstract reports on data presented at the 2023 International Anal Neoplasia Society. Background: Anal cancer disproportionately affects gay, bisexual, and other men who have sex with men (GBM), as well as transgender women (TGW). Current recommendations suggest anal cancer screening, specifically anal cytology, for high-risk populations, particularly GBM/TGW living with HIV. This study […]

The Anal Cancer Knowledge Scale (PACKS)

Anal cancer disproportionately impacts Black and Hispanic men who have sex with men and transgender women (MSM/TGW) who have high rates of HIV. Lack of anal cancer information is a major barrier to the utilization of primary and secondary prevention (i.e., vaccination and screening). The purpose of this study was to evaluate the construct validity […]